Dynamic Intelligence
Actionable Business Intelligence to Accelerate Complex Decision-making.
Dynamism in Perspective
We're driven by the digitalization of intelligence and visualization of solutions. As a leading value science company, Syenza offers Dynamic Intelligence services using simulation modelling, data ecosystems, and digital analytics. We deliver actionable business intelligence to accelerate complex decision-making, insight discovery and process optimization.
Simulation modeling
Syenza uses simulation modelling
to safely experiment with “what
if scenarios” especially when
healthcare systems are
characterized by high uncertainty,
complexity, and dynamism.
We forecast and quantify the
impact on your business and
market access ahead of time.
Data Ecosystem Curation
Syenza produces evidence with
empirical data – the greatest
obstacle in HEOR and and
Global Market Access. We
curate an ecosystem of cost
data, patient registry data and
clinical outcomes data. We also
manage the big data value chain
including data acquisition, data
quality management, security
and storage.
Digital Analytics
Syenza deploys scientifically robust and state-of-the-art digital analytics to reveal the fusion of multiple perspectives on value. Data from patients, prescribers, and payers are core to the differentiated value attributes that emerge
from our digital analytics.
Service Outcomes
Clients use simulation models to gain insights of market opportunities and risks under different scenarios for market shaping purposes.
Clients access the multi-source data ecosystem for business critical projects. In short, Syenza takes the pain out of data so you can gain value.
Clients leverage rich descriptive reports that include market opportunities and empirical insights to inform scenarios for predictive modelling.
View Our Recent Articles
AI Clinician in Pediatric ICU: A Review and HEOR P...
🤖 What could AI Clinician support mean for pediatric ICU care? A new collaboration between Imperial College London and CHOC is developing an AI system to guide treatment decisions in PICUs. This article...
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals...
🔍 Are we truly getting the full story on high-cost medications like ticagrelor? A recent BMJ investigation has raised alarm bells over the integrity of data from pivotal studies on AstraZeneca’s ticagrelor,...
Pluvicto Prostate Cancer Trial: Phase III Results
🔍 Have you heard about the latest breakthrough in prostate cancer treatment? Novartis’s Pluvicto™ has shown significant clinical benefits in earlier-stage prostate cancer, highlighting its potential to...
